Growth Metrics

Standard Biotools (LAB) Convertible Debt (2014 - 2026)

Standard Biotools (LAB) reported Convertible Debt of $299000.0 for Q1 2026, little changed year-over-year from $299000.0 in Q1 2025, and little changed on a QoQ basis from $299000.0 in Q4 2025.

Standard Biotools (LAB) has 13 years of Convertible Debt data on file, last reported at $299000.0 in Q1 2026.

  • Quarterly Convertible Debt changed 0.0% year-over-year to $299000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $299000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $299000.0, changed 0.0% from the prior year.
  • Convertible Debt held at $299000.0 in Q1 2026 per LAB's latest filing, from $299000.0 in the prior quarter.
  • Across five years, Convertible Debt topped out at $55.0 million in Q3 2023 and bottomed at $299000.0 in Q1 2024.
  • The 5-year median for Convertible Debt is $299000.0 (2024), against an average of $22.7 million.
  • The widest annual swing landed in 2023, when Convertible Debt gained 0.87%; it then tumbled 99.46% in 2024.
  • Tracing LAB's Convertible Debt over 5 years: stood at $54.6 million in 2022, then tumbled by 98.96% to $569000.0 in 2023, then sank by 47.45% to $299000.0 in 2024, then changed by 0.0% to $299000.0 in 2025, then changed by 0.0% to $299000.0 in 2026.
  • Per Business Quant, the three latest LAB Convertible Debt figures stand at $299000.0 (Q1 2026), $299000.0 (Q4 2025), and $299000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Standard Biotools 448.37 Mn -6.80 Mn 11.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 299,000.00
Dec 31, 2025 299,000.00
Sep 30, 2025 299,000.00
Jun 30, 2025 299,000.00
Mar 31, 2025 299,000.00
Dec 31, 2024 299,000.00
Sep 30, 2024 299,000.00
Jun 30, 2024 299,000.00
Mar 31, 2024 299,000.00
Dec 31, 2023 569,000.00
Sep 30, 2023 54.98 Mn
Jun 30, 2023 54.85 Mn
Mar 31, 2023 54.73 Mn
Dec 31, 2022 54.62 Mn
Sep 30, 2022 54.50 Mn
Jun 30, 2022 54.38 Mn
Mar 31, 2022 54.27 Mn
Dec 31, 2021 54.16 Mn
Sep 30, 2021 54.05 Mn
Jun 30, 2021 53.94 Mn
Mar 31, 2021 53.84 Mn
Dec 31, 2020 54.22 Mn
Sep 30, 2020 54.12 Mn
Jun 30, 2020 54.01 Mn
Mar 31, 2020 53.92 Mn
Dec 31, 2019 53.82 Mn
Sep 30, 2019 49.85 Mn
Jun 30, 2019 49.83 Mn
Mar 31, 2019 49.78 Mn
Dec 31, 2018 172.06 Mn
Sep 30, 2018 169.35 Mn
Jun 30, 2018 166.76 Mn
Mar 31, 2018 164.16 Mn
Dec 31, 2017 195.24 Mn
Sep 30, 2017 195.17 Mn
Jun 30, 2017 195.09 Mn
Mar 31, 2017 195.02 Mn
Dec 31, 2016 194.95 Mn
Sep 30, 2016 194.88 Mn
Jun 30, 2016 194.81 Mn
Mar 31, 2016 194.74 Mn
Dec 31, 2015 194.67 Mn
Sep 30, 2015 195.63 Mn
Jun 30, 2015 195.57 Mn
Mar 31, 2015 195.51 Mn
Dec 31, 2014 195.46 Mn
Sep 30, 2014 195.40 Mn
Jun 30, 2014 195.34 Mn
Mar 31, 2014 195.25 Mn